Novolin 70/30 is a Subcutaneous Injection, Suspension in the Human Otc Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Human.
Product ID | 0169-1837_38a9e6ee-ad2c-432b-b598-0c339d873975 |
NDC | 0169-1837 |
Product Type | Human Otc Drug |
Proprietary Name | Novolin 70/30 |
Generic Name | Human Insulin |
Dosage Form | Injection, Suspension |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 1991-06-25 |
Marketing Category | BLA / NDA |
Application Number | BLA019991 |
Labeler Name | Novo Nordisk |
Substance Name | INSULIN HUMAN |
Active Ingredient Strength | 100 [iU]/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1991-06-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019991 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 1991-06-25 |
Marketing Category | NDA |
Application Number | NDA019991 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 1991-06-25 |
Ingredient | Strength |
---|---|
INSULIN HUMAN | 100 [iU]/mL |
SPL SET ID: | 508a2763-3cb7-4be5-9e53-544e84cd9b1f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0169-1833 | Novolin | Human Insulin |
0169-1834 | Novolin | Human Insulin |
0169-1837 | Novolin | Human Insulin |
0169-3003 | Novolin | Human Insulin |
0169-3004 | Novolin | Human Insulin |
0169-3007 | Novolin | Human Insulin |
50090-0403 | Novolin | Human Insulin |
50090-0497 | Novolin | Human Insulin |
50090-0498 | Novolin | Human Insulin |
64725-1833 | Novolin | Human Insulin |
64725-1834 | Novolin | Human Insulin |
64725-1837 | Novolin | Human Insulin |
68071-1701 | Novolin | Human Insulin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NOVOLIN 73498651 1384926 Live/Registered |
NOVO INDUSTRI A/S 1984-09-10 |